Atebion BDS has been established to provide a complete range of business development services on a personalised, client specific basis.
Atebion BDS
We perform technical and commercial evaluations of drug candidates, advise on clinical development strategies & portfolio priorities, provide full BD support services and help to secure investment for biotechs and university spin-outs. We have a solid track-record of deal making for local, regional, multi-regional and global geographies as well as in securing investment for early-stage discovery & development companies.
0+
Projects
0
Associates
0
Years Of (Combined) Experience
0%
Quality
Partners
Our Background
Probability of commercial success is different from probability of clinical success. Atebion BDS believes that early commercial insight to a disease target product profile (DTPP) or a candidate’s target profile (TPP) is a prerequisite for success, whether this relates to completing an in- or out-license or a successful product launch.
High quality techno-commercial evaluations represent a core component of all our services.
